Startup funding Northern Netherlands | Q3 2026

Q3 2026 kept capital flowing into the Northern Netherlands, with seven companies closing funding between July and September. The deals span circular chemistry, green hydrogen, energy software, diagnostics and European AI.

The range runs from a renewable aromatics plant in Delfzijl to a blood test that reads 7,500 proteins from a single drop. Together they show a region that pairs university research with its energy-transition industry. A century-old Groningen packaging group also brought in its first outside shareholder.

Startup and scale-up performance in Q3

Q3 2026 was a quarter of quiet deals. Of the seven rounds, only one amount is public: Limosa Immunodiagnostics' €350K convertible loan from Future Tech Ventures. The other six were undisclosed, although BioBTX's financing of a full commercial plant is by far the largest in scope.

The table below provides an overview of the sectors in which the companies are active:

‍

‍

Where did the funds come from?

Future Tech Ventures (FTV) was again the most active investor, backing three of the seven ventures: Limosa Immunodiagnostics, ProteoGuide and Powerchainger. NOM appeared twice, in BioBTX and Holthausen Energy Points. The other rounds brought in a wider mix of capital:

• BioBTX: equity from Invest-NL, Infinity Recycling, Covestro, NOM and Carduso Capital, loans from Colesco Capital, FEAS (Nij Begun) and the Province of Groningen, and an RVO DEI+ subsidy. It is the most layered capital stack of the quarter.
• NNZ Packaging: Amsterdam-based private equity firm Foreman Capital became the first external shareholder in the group's 104-year history.
• HostYourAI: a round led by Benelux venture fund Volta Ventures.
• Powerchainger: Carteman Ventures led the round, with Groninger Groeifonds and FTV joining.

‍

Looking at the numbers, three clear patterns emerge:

1. The energy transition as anchor: three of the seven deals (BioBTX, Holthausen Energy Points and Powerchainger) target chemistry, hydrogen and grid flexibility. The region's energy heritage is turning into a new industrial base.
2. Blended capital stacks: public money is de-risking private investment. BioBTX combined equity, Nij Begun and provincial loans and an RVO subsidy, while Limosa paired FTV's investment with an SNN subsidy.
3. Diagnostics from the knowledge base: Limosa (a University of Groningen spin-off, validated with UMCG) and ProteoGuide (working with UMCG and biobanks) were both founded in 2026 and funded within months.

The funding sources show the layers of the regional ecosystem. FTV provides the first cheque for science-based startups, NOM and Groninger Groeifonds back growth, and national, corporate and private equity investors step in at scale.

‍

Closing thoughts

Q3 2026 was less about headline amounts and more about breadth. Funding reached first-year spin-offs like Limosa and ProteoGuide, scale-ups like Powerchainger and HostYourAI, and established players building plants and adding shareholders.

FTV, NOM, Groninger Groeifonds and SNN remain the local foundation. National and corporate investors such as Invest-NL and Covestro, plus private equity, are joining as projects scale. With energy and health innovation leading the way, the Northern Netherlands continues to turn research and regional strengths into fundable companies.